Cortical changes in cholecystokinin mRNA are related to spontaneous pain behaviors following excitotoxic spinal cord injury in the rat

Molecular Brain Research

Volumn 118, Issue 1-2, 2003, Pages 171-174

  Brewer, Kori L ^a   McMillan, David ^a   Nolan, Todd ^a   Shum, Kerry ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Excitotoxicity; Neuropathic pain; Quisqualic acid; Slot blot

Indexed keywords

CHOLECYSTOKININ; MESSENGER RNA; QUISQUALIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CONTROLLED STUDY; DIENCEPHALON; MESENCEPHALON; NEUROPATHIC PAIN; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; TISSUE DISTRIBUTION; UPREGULATION;

ANIMALIA;

EID: 0141920747     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2003.08.006     Document Type: Article

References (40)

1. Abraham K.E., Brewer K.L., McGinty J.F. Opioid peptide messenger RNA expression is increased at spinal and supraspinal levels following excitotoxic spinal cord injury. Neuroscience. 99(1):2000;189-197.
2. Abraham K.E., McGinty J.F., Brewer K.L. Spinal and supraspinal changes in opioid mRNA expression are related to the onset of pain behaviors following excitotoxic spinal cord injury. Pain. 90(1-2):2001;181-190.
3. Bethea J.R., Dietrich W.D. Targeting the host inflammatory response in traumatic spinal cord injury. Curr. Opin. Neurol. 15(3):2002;355-360.
4. Brewer K.L., McMillan D.B., Shum K. Supraspinal changes in gene expression are correlated with spontaneous pain behaviors following excitotoxic spinal cord injury. Soc. Neurosci. Abstr. 2002;53.14.
5. Christensen M.D., Hulsebosch C.E. Chronic pain after spinal cord injury. J. Neurotrauma. 14:1997;517-537.
6. Christensen M.D., Everhart A.W., Pickelman J., Hulsebosch C.E. Mechanical and thermal allodynia in chronic central pain following spinal cord injury. Pain. 68:1996;517-537.
7. Coudore-Civiale M., Courteix C., Fialip J., Boucher M., Eschalier A. Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats. Pain. 88:2000;15-22.
8. Faris P.L., Komisaurk B.R., Watkins L.R., Meyer D.J. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science. 219:1983;310-312.
9. Friedrich A.E., Gebhart G.F. Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat. Pharmacol. Ther. Interven. 292(2):2000;538-544.
10. Gorman L.A., Yu C.-G., Ruenes G.L., Daniels L., Yezierski R.P. Conditions affecting the onset, severity and progression of a spontaneous pain-like behavior after excitotoxic spinal cord injury. J. Pain. 2(4):2001;229-240.
11. Gustafson H., Stiller C., Brodin E. Peripheral axotomy increases cholecystokinin release in the rat anterior cingulate cortex. NeuroReport. 11(15):2000;3345-3348.
12. Hansen T.V., Rehfeld J.F., Nielsen F.C. Mitogen-activated protein kinase and protein kinase A signaling pathways stimulate cholecystokinin transcription via activation of cyclic adenosine 3′,5′-monophosphate response element-binding protein. Mol. Endocrinol. 13(3):1999;466-475.
13. Hubscher C.H., Johnson R.D. Changes in neuronal receptive field characteristics in caudal brain stem following chronic spinal cord injury. J. Neurotrauma. 16:1999;533-541.
14. Hulsebosch C.D., Xu G.-Y., Perez-Polo J., Westlund K., McAdoo D.J. Rodent model of chronic central pain after spinal cord contusion injury. J. Neurotrauma. 17(12):2000;1205-1217.
15. Idanpaan-Heikkila G.G., Kayser V. Prevention of tolerance to antinociceptive effects of systemic morphine by a selective cholecystokinin-B receptor antagonist in a rat model of peripheral neuropathy. Pharmacol. Exp. Ther. 282(3):1997;1366-1372.
16. Kaupila T. Correlation between autotomy behavior and current theories of neuropathic pain. Neurosci. Biobehav. Rev. 23:1998;111-129.
17. Kovelowski C.J., Ossipov M.H., Sun H., Lai J., Malan T.P. Jr., Porreca F. Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat. Pain. 87:2000;265-273.
18. Lenz F.A., Tasker R.R., Dostrovsky J.O., Kwan H.C., Gorecki S., Hirayama T., Murphy J.T. Abnormal single unit activity recorded in the somatosensory thalamus of a quadriplegic patient with central pain. Pain. 31:1987;225-236.
19. Lenz F.A., Lee J.I., Garonzik I.M., Rowland L.H., Dougherty P.M., Hua S.E. Plasticity of pain-related neuronal activity in the human thalamus. Prog. Brain Res. 129:2000;259-273.
20. Melzack R. Pain and the neuromatrix in the brain. J. Dent. Educ. 65:2001;1378-1382.
21. Morrow T.J., Paulson P.E., Brewer K.L., Yezierski R.P., Casey K.L. Chronic, selective forebrain responses to excitotoxic dorsal horn injury. Exp. Neurol. 161:2000;220-226.
22. O'Neill M., Dourish C., Iversen S. Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329. Neuropharmacology. 28:1989;243-247.
23. 2 receptor in mice results in an upregulation of the endogenous opioid system. J. Neurosci. 22(5):2002;2005-2011.
24. Popovich P.G., Wei P., Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377(3):1997;443-464.
25. Przewlocki R., Przewlocka B. Opioids in chronic pain. Eur. J. Pharmocol. 429(1-3):2001;179-185.
26. Sandkuhler J. Learning and memory in pain pathways. Pain. 88:2000;113-118.
27. Siddall P.J., Loeser J.D. Pain following spinal cord injury. Spinal Cord. 39:2001;63-73.
28. Tachibana T., Miki K., Fukuoka T., Arakawa A., Taniguchi M., Maruo S., Noguchi K. Dynorphin mRNA expression in dorsal horn neurons after traumatic spinal cord injury: temporal and spatial analysis using in situ hybridization. J. Neurotrauma. 15(7):1998;485-494.
29. Wang Z., Gardell L.R., Ossipov M.G., Vanderah T.W., Brennan M.B., Gochgeschwender U., Hruby V.J., Malan T.P. Jr., Lai J., Porreca F. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J. Neurosci. 21(5):2001;1779-1786.
30. Watkins L.R., Kinscheck I.B., Mayer D.J. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide. Science. 224:1984;395-396.
31. Weng H.R., Lee J.I., Lenz F.A., Schwartz A., Vierck C., Rowland L., Dougherty P.M. Functional plasticity in primate somatosensory thalamus following chronic lesion of the ventral lateral spinal cord. Neuroscience. 101:2000;393-401.
32. Wiesenfeld-Hallin Z., Xu X. The role of cholecystokinin in nociception, neuropathic pain and opiate tolerance. Reg. Pept. 65:1996;23-28.
33. Williams R.G., Dimaline R., Varro A., Isetta A.M., Trizio D., Dockray G.J. Cholecystokinin octapeptide in rat central nervous system: immunocytochemical studies using a monoclonal antibody that does not react with CGRP. Neurochem. Int. 11:1987;433-442.
34. Xu X., Hao J., Seiger A., Hughes J., Hokfelt T., Wiesenfeld-Hallin Z. Chronic pain-related behaviors in spinally injured rats: evidence for functional alterations of the endogenous cholecystokinin and opioid systems. Pain. 56:1994;271-277.
35. Xu X., Alster P., Wu W., Hao J., Wiesenfeld-Hallin Z. Increased level of cholecystokinin in cerebrospinal fluid is associated with chronic pain-like behavior in spinally injured rats. Peptides. 22:2001;1305-1308.
36. Yakovlev A.G., Faden A.I. Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury. Mol. Chem. Neuropathol. 23:1994;179-190.
37. Yezierski R.P. Pain following spinal cord injury: the clinical problem and experimental studies. Pain. 68:1996;185-194.
38. Yezierski R.P. Pain following spinal cord injury: pathophysiology and central mechanisms. Prog. Brain Res. 129:2000;429-449.
39. Yezierski R.P., Park S.H. The mechanosensitivity of spinal sensory neurons following intraspinal injections of quisqualic acid in the rat. Neurosci. Lett. 157:1993;115-119.
40. Yezierski R.P., Liu S., Ruenes G.L., Kajander K.J., Brewer K.L. Excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model. Pain. 75:1998;141-155.